Beta Drugs (NSE:BETA) EV-to-OCF: (As of Sep. 04, 2026)

Beta Drugs  (NSE:BETA) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Beta Drugs's PE Ratio (TTM) for today is calculated as:

Beta Drugs's share price for today is ₹2258.90.
Beta Drugs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹44.214.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Beta Drugs EV-to-OCF Related Terms

The historical data trend for Beta Drugs's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beta Drugs EV-to-OCF Chart

Beta Drugs Annual Data
	Trend	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24	Mar25	Mar26
EV-to-OCF		Get a 7-Day Free Trial					18.46	25.83	37.90	52.93	32.52

Beta Drugs Quarterly Data
	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
EV-to-OCF	Get a 7-Day Free Trial															0.00	0.00	0.00	32.52	0.00

NSE:BETA vs ZTS: EV-to-OCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Beta Drugs's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beta Drugs EV-to-OCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beta Drugs's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Beta Drugs's EV-to-OCF falls into.

Beta Drugs EV-to-OCF Calculation

Beta Drugs's EV-to-OCF for today is calculated as:

Beta Drugs's current Enterprise Value is ₹22,878 Mil.
Beta Drugs's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beta Drugs Business Description